The analysis is based on results from the STEP 1 trial, published in 2021 in the New England Journal of Medicine , which showed the 2.4 mg dosage of semaglutide approved by the FDA for the treatment of obesity reduced body weight by an average of 14.9% along with reductions in several cardiovascular risk factors such as blood pressure and lipids
Diabetes Care 42 (9), 17241732
30-53% of new cases are directly linked to obesity
It is associated with vascular abnormalities, skin and organ fibrosis, immune dysfunction, and excessive deposition of extracellular matrix, affecting multiple organs including the skin, lungs, stomach, and kidneys
It acts as a cofactor for collagen production and helps regenerate glutathione in the body
Get rid of stubborn upper arm fat and take the first step toward smoother, more sculpted arms book your session with Turkey Luxury Clinics , get a price quote , and enjoy professional care with visible results